Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-γ binding agents with potential application to the treatment of osteoporosis
- 21 August 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (21) , 5659-5663
- https://doi.org/10.1016/j.bmcl.2006.08.003
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Indol-1-yl Acetic Acids as Peroxisome Proliferator-Activated Receptor Agonists: Design, Synthesis, Structural Biology, and Molecular Docking StudiesJournal of Medicinal Chemistry, 2006
- Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fatBone, 2005
- Selective PPARγ modulators with improved pharmacological profilesBioorganic & Medicinal Chemistry Letters, 2005
- Exploring the Binding Site Structure of the PPARγ Ligand-Binding Domain by Computational Solvent MappingBiochemistry, 2004
- A New Class of Peroxisome Proliferator-activated Receptor Agonists with a Novel Binding Epitope Shows Antidiabetic EffectsJournal of Biological Chemistry, 2004
- Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implicationsCurrent Opinion in Pharmacology, 2004
- A Novel Potent Antagonist of Peroxisome Proliferator-Activated Receptor Blocks Adipocyte Differentiation But Does Not Revert the Phenotype of Terminally Differentiated AdipocytesEndocrinology, 2001
- A Selective Peroxisome Proliferator-Activated Receptor- (PPAR ) Modulator Blocks Adipocyte Differentiation but Stimulates Glucose Uptake in 3T3-L1 AdipocytesMolecular Endocrinology, 2000
- Synthesis and biological activity of a novel series of indole-derived PPARγ agonistsBioorganic & Medicinal Chemistry Letters, 1999
- Palladium-Catalyzed Cross-Coupling Reactions of Organoboron CompoundsChemical Reviews, 1995